Literature DB >> 19921104

What you should know about the 2008 American College of Chest Physicians evidence-based clinical practice guidelines (8th) on antithrombotic and thrombolytic therapy.

Scott Kaatz1.   

Abstract

The American College of Chest Physicians published their first consensus conference guidelines on antithrombotic therapy in 1986 and has updated these guidelines approximately every 3 years as a supplement to the journal Chest. These guidelines are widely accepted as an authoritative source of information and considered by many to be the textbook for antithrombotic therapy. The most recent guidelines are from the 8th consensus conference, published in 2008, and this article will highlight new recommendations that have evolved since the 2004 Chest supplement. Examples from the literature that support the evolution these guidelines will focus on changes that are most germane to the majority of attendees at the 10th National Conference on Anticoagulant Therapy and members of the AC Forum. The objective of this article is to help answer ten common clinical questions frequently faced by anticoagulation management services.

Mesh:

Substances:

Year:  2010        PMID: 19921104     DOI: 10.1007/s11239-009-0415-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  34 in total

1.  Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin.

Authors:  Elizabeth Sconce; Peter Avery; Hilary Wynne; Farhad Kamali
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  Reflecting on eight editions of the American College of Chest Physicians antithrombotic guidelines.

Authors:  Jack Hirsh; Gordon Guyatt; Sandra Zelman Lewis
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

3.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Authors:  E M Hylek; Y C Chang; S J Skates; R A Hughes; D E Singer
Journal:  Arch Intern Med       Date:  2000-06-12

4.  Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

Authors:  M A Crowther; J Julian; D McCarty; J Douketis; M Kovacs; L Biagoni; T Schnurr; J McGinnis; M Gent; J Hirsh; J Ginsberg
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

5.  Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial.

Authors:  David B Matchar; Gregory P Samsa; Stuart J Cohen; Eugene Z Oddone; Annette E Jurgelski
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

6.  Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Gordon H Guyatt; Deborah J Cook; Roman Jaeschke; Stephen G Pauker; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Authors:  David A Garcia; Susan Regan; Mark Crowther; Elaine M Hylek
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

Review 10.  Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.

Authors:  Kirsten Neudoerffer Kangelaris; Stephen Bent; Robert L Nussbaum; David A Garcia; Jeffrey A Tice
Journal:  J Gen Intern Med       Date:  2009-03-21       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.